Granisetron skin patch versus ondansetron for transplant nausea
Treatments studied
Part of Digestive system clinical trials.
This study compares a granisetron skin patch to ondansetron tablets/medicine to see which works better to prevent nausea and vomiting around stem cell transplant. It may help your care team choose the most effective anti-nausea option for transplant patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old and getting either an autologous or allogeneic stem cell transplant with pre-treatment (a preparative regimen)
- Have not had vomiting in the 24 hours before starting the study
- Have not used certain anti-nausea/anti-mental health medicines (specific antipsychotics like risperidone, quetiapine, clozapine, and related types) within 30 days before enrollment, and not plan to use them during the study
- Do not have a known allergy to granisetron (the study medicine)
- Do not be taking amifostine at the same time as this study treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of ondansetron (a nausea prevention drug) in people getting cisplatin chemotherapy plus a PD-1 inhibitor. It aims to find which dosing schedule works best to prevent nausea and vomiting.
This trial compares two anti-nausea drug regimens (one with olanzapine, one with dexamethasone) to prevent delayed nausea and vomiting after a stem cell transplant for multiple myeloma. It aims to find which is better at controlling these side effects.
This trial compares two forms of ondansetron (a nausea medicine) — a dissolving film you put in the mouth versus a needle injection — to see which works better in preventing nausea and vomiting caused by chemotherapy in children with solid tumors.
This study tests whether acupuncture can reduce nausea and vomiting that often occur after a stem cell transplant. If you are scheduled for a transplant, this treatment might help you feel better during recovery.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
This trial tests whether a lower dose of olanzapine (2.5 mg) works as well as the usual dose (5 mg) for preventing nausea and vomiting caused by high-dose melphalan chemotherapy. It is for people receiving their own stem cell transplant.
Hear when a new Nausea With Vomiting Chemotherapy-Induced trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.